Gilpin Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$110K Buy
95
+43
+83% +$50.7K 0.07% 184
2026
Q2
$62.4K Hold
52
– – 0.04% 204
2026
Q1
$47.8K Buy
52
+2
+4% +$2.03K 0.04% 198
2025
Q4
$53.7K Buy
+50
New +$47.8K 0.04% 189

Other funds holding LLY

Gilpin Wealth Management's LLY Position: Q3 2026 in Review

Gilpin Wealth Management increased its Eli Lilly (LLY) stake by 83% in Q3 2026, buying an estimated $50.7K and bringing the position to 95 shares worth $110K. The position accounts for 0.07% of the portfolio, ranked #184.

Gilpin Wealth Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 255 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Gilpin Wealth Management held 95 shares of Eli Lilly worth $110K as of Q3 2026.
  • Gilpin Wealth Management bought 43 Eli Lilly shares in Q3 2026, an estimated $50.7K.
  • Eli Lilly made up 0.07% of Gilpin Wealth Management's portfolio in Q3 2026, its #184 holding.
  • Gilpin Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 255 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.